Showing results (361-370 of 435) with videos related to
Sort By:
Pageof 44
Proceedings of the National Academy of Sciences of the United States of America|February 2, 2011
Nε-lysine acetylation determines dissociation from GAP junctions and lateralization of connexin 43 in normal and dystrophic heartClaudia Colussi, Jessica Rosati, Stefania Straino, et al.Cancers|May 11, 2024
Deregulation of New Cell Death Mechanisms in LeukemiaGregorio Favale, Federica Donnarumma, Vincenza Capone, et al.Cell Death & Disease|March 24, 2026
Dynamic epigenetic regulation of BCLAF1 splicing in acute myeloid leukemiaGiulia Sgueglia, Crescenzo Massaro, Annamaria Muro, et al.Clinical Epigenetics|December 22, 2023
In-silico guided chemical exploration of KDM4A fragments hitsJessica Lombino, Rosario Vallone, Maura Cimino, et al.Ageing Research Reviews|June 1, 2025
"Aging and epigenetic implications in radiotherapy: The promise of BNCT"Chiara Papulino, Marco Crepaldi, Gregorio Favale, et al.European Journal of Medicinal Chemistry|November 17, 2020
Novel quinolone-based potent and selective HDAC6 inhibitors: Synthesis, molecular modeling studies and biological investigationNicola Relitti, A Prasanth Saraswati, Giulia Chemi, et al.Journal of Experimental & Clinical Cancer Research : CR|June 14, 2024
Three-dimensional environment sensitizes pancreatic cancer cells to the anti-proliferative effect of budesonide by reprogramming energy metabolismEduardo Ibello, Federica Saracino, Donatella Delle Cave, et al.Biology Open|October 30, 2013
The class I-specific HDAC inhibitor MS-275 modulates the differentiation potential of mouse embryonic stem cellsGianluigi Franci, Laura Casalino, Francesca Petraglia, et al.Journal of Experimental & Clinical Cancer Research : CR|October 1, 2025
MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interactionMarco Bocchetti, Alessia Maria Cossu, Manuela Porru, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 1, 2016
c-Myc Modulation and Acetylation Is a Key HDAC Inhibitor Target in CancerAngela Nebbioso, Vincenzo Carafa, Mariarosaria Conte, et al.Pageof 44